Actinic keratosis market seen reaching $11.06 billion by 2030

The Business Research Company says the actinic keratosis market will grow from $8.42 billion in 2025 to $8.91 billion in 2026, then reach $11.06 billion by 2030. Rising sunburn rates, wider dermatology access and new treatment approaches are driving demand, with North America leading today and Asia-Pacific expected to grow fastest.

Why it matters: - Actinic keratosis is a precancerous skin condition, so market growth tracks demand for earlier diagnosis and treatment that can help prevent progression to squamous cell carcinoma. - Rising cases of sunburn and UV exposure are increasing the need for topical therapies, procedures and ongoing dermatology care. - The forecast points to stronger demand for non-invasive and combination treatments across hospitals, dermatology clinics and homecare settings.

What happened: - The Business Research Company released a 2026 actinic keratosis market report covering market size, growth drivers, segmentation trends and key competitors. - The report values the market at $8.42 billion in 2025 and $8.91 billion in 2026, implying 5.8% annual growth. - The market is projected to reach $11.06 billion by 2030, growing at a 5.6% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report includes coverage of Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also published a free sample of the report and the full market report.

The details: - The report says growth has been supported by higher ultraviolet exposure, more frequent sunburn cases, limited availability of effective topical treatments, rising skin cancer prevalence, stronger dermatology infrastructure and broad use of conventional surgical interventions. - The report says future growth will be supported by advanced photodynamic therapies, wider use of combination treatments, expansion of hospital and dermatology clinic networks, greater awareness of early detection and treatment, and new homecare options. - Expected trends include stronger sun protection awareness, greater preference for non-invasive photodynamic therapy, increased use of topical therapies for early-stage AK, more dermatology clinics and homecare treatment solutions, and more combination therapy use. - Actinic keratosis, also called solar keratosis, is caused by long-term exposure to ultraviolet radiation from sunlight or artificial sources. - The condition appears as rough, scaly or crusty patches on sun-exposed areas such as the face, scalp, hands and arms. - Timely treatment is important because AK can be an early form of squamous cell carcinoma. - The report says regular skin exams and effective sun protection are important for management and risk reduction. - The report identifies rising severe sunburns as a key growth driver. - UV damage can alter DNA in skin cells and create precancerous lesions, especially after repeated or prolonged exposure. - In May 2024, Melanoma Focus reported 201 hospital admissions attributed to sunburn during 2022-23, including 89 children and 25 infants under one year old. - Melanoma Focus also reported that 66% of UK adults aged 16-65 recalled childhood sunburn, and 65% of those cases involved severe blistering. - That share rose to 77% among people with light or pale skin tones. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

Between the lines: - The market is expanding because prevention and treatment needs are converging: more people are exposed to UV risk, while clinicians are increasingly using a mix of topical, procedural and newer non-invasive options. - The report’s emphasis on homecare and combination therapy suggests treatment is moving beyond traditional surgical care alone. - North America’s current lead and Asia-Pacific’s faster forecast growth point to a mature market in one region and broader adoption potential in another.

What's next: - Demand is likely to increase as consumers and providers focus more on early detection, sun protection and treatment of pre-cancerous lesions. - New photodynamic and homecare offerings could change how AK is treated in outpatient and at-home settings. - Regional growth in Asia-Pacific will be a key indicator of how quickly access to dermatology care broadens outside established markets.

The bottom line: - Actinic keratosis is moving from a niche dermatology category to a broader growth market, powered by UV-related skin damage, rising awareness and more treatment options.